Change - Announcement of Cessation::Retirement of Independent Director, Mr Kee Teck Koon
December 01, 2021 at 09:01 am EST
Share
Change - Announcement of Cessation::Retirement of Independent Director, Mr Kee Teck Koon
Issuer & Securities
Issuer/ ManagerRAFFLES MEDICAL GROUP LTDSecuritiesRAFFLES MEDICAL GROUP LTD - SG1CH4000003 - BSL
Stapled SecurityNo
Announcement Details
Announcement Title Change - Announcement of CessationDate &Time of Broadcast 01-Dec-2021 19:00:16Status NewAnnouncement Sub TitleRetirement of Independent Director, Mr Kee Teck KoonAnnouncement ReferenceSG211201OTHRSAJRSubmitted By (Co./ Ind. Name)Kimmy GohDesignationCompany SecretaryDescription (Please provide a detailed description of the event in the box below)Retirement of Mr Kee Teck Koon as a Non-Executive Independent Director.
Additional Details
Name Of PersonMr Kee Teck KoonAge65Is effective date of cessation known?YesIf yes, please provide the date31/12/2021Detailed Reason (s) for cessationAs part of the Board rejuvenation process and good corporate governance practice, Mr Kee Teck Koon will retire from the Board on 31 December 2021. Mr Kee has served on the Board for more than 9 years and was also the Chairman of the Audit & Risk Committee during his tenure of service.
The Board of Directors and the Company would like to record our appreciation to Mr Kee for his invaluable contributions and guidance during his tenure as an Independent Director of the Company.Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?NoIs there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?NoAny other relevant information to be provided to shareholders of the listed issuer?NoDate of Appointment to current position03/01/2012Does the AC have a minimum of 3 members (taking into account this cessation)?YesNumber of Independent Directors currently resident in Singapore (taking into account this cessation)7Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months2Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)Non-Executive and Independent DirectorRole and responsibilitiesNon-Executive and Independent Director Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiariesNoneShareholding interest in the listed issuer and its subsidiaries?YesShareholding Details1. Direct Interest - 329,588 Raffles Medical Group Ltd Ordinary Shares
2. Date of Grant - 3 April 2017
Options to subscribe for Ordinary Shares in Raffles Medical Group Ltd - 75,000
Option price per share - S$1.42
3. Date of Grant - 3 September 2018
Options to subscribe for Ordinary Shares in Raffles Medical Group Ltd - 100,000
Option price per share - S$1.09
4. Date of Grant - 1 July 2019
Options to subscribe for Ordinary Shares in Raffles Medical Group Ltd - 150,000
Option price per share - S$1.04
5. Date of Grant - 5 October 2020
Options to subscribe for Ordinary Shares in Raffles Medical Group Ltd - 250,000
Option price per share - S$0.81
6. Date of Grant - 1 September 2021
Options to subscribe for Ordinary Shares in Raffles Medical Group Ltd - 200,000
Option price per share - S$1.40Past (for the last 5 years)1. CapitaLand Limited (Director)
2. Lien Foundation (Director)
3. Fullerton Fund Management Company Ltd (Director)
4. FFMC Holdings Pte. Ltd. (Director)
5. Changi Airports International Pte. Ltd. (Director)
6. CapitaLand Pte. Ltd. (Director)Present1. Raffles Medical Group Ltd (Director)
2. NTUC Enterprise Co-operative Limited (Director and Board Adviser)
3. NTUC Income Insurance Co-operative Limited (Director and Deputy Chairman)
4. Mandai Park Holdings Pte. Ltd. (Director)
5. NTUC Fairprice Co-operative Limited (Director)
6. Changi Airport Group (Singapore) Pte. Ltd. (Director)
7. CapitaLand Investment Limited (CLI) (Director)
8. SC Bank Solutions (Singapore) Limited (Director)
9. Trust Bank Singapore Limited (Director)
Related Announcements
Related Announcements
Attachments
Original Link
Original Document
Permalink
Disclaimer
Raffles Medical Group Ltd. published this content on 01 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 December 2021 14:00:11 UTC.
Raffles Medical Group Ltd is a Singapore-based integrated private healthcare provider. The principal activities of the Company are those relating to the operation of medical clinics, other general medical services, and investment holdings. The Companyâs segments include Healthcare Services, Hospital Services, and Investment Holdings. The Healthcare Services segment is engaged in the operations of medical clinics and other general medical services; provision of health insurance, trading in pharmaceutical and nutraceutical products and diagnostic equipment, and provision of management and consultancy services. The Hospital Services segment is engaged in the provision of specialized medical services and operation of hospital and business of medical laboratory and imaging center. The Investment Holdings segment is engaged in investment holding and those relating to investment properties. It operates medical facilities in about 14 cities in Singapore, China, Japan, Vietnam, and Cambodia.